Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. NASDAQ OMX GlobeNewswire Message Board

Marel Q3 2013 results (All amounts in EUR)

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 301275
Posted On: 10/23/2013 12:30:11 PM
Avatar
Posted By: News Desk 2018
Marel Q3 2013 results

(All amounts in EUR)

  • Revenues for Q3 2013 totalled 156.9 million (m), a decrease of 4.5% compared to the same quarter of 2012 [164.3m].
  • EBITDA was 19.5m or 12.4% of revenues [Q3 2012: 20.5m].
  • Operating profit (EBIT) was 12.9 or 8.2% of revenues [Q3 2012:  14.1m].
  • Net result for Q3 2013 was 6.0 [Q3 2012: 8.4m]. Earnings per share were 0.81 euro cents [Q3 2012: 1.15 euro cents].
  • Cash flow from operating activities before interest and tax was 3.0m and 45.6 m YTD.  [YTD 2012: 37.0m]. Net interest bearing debt was 239.0m at the end of the quarter compared to 261.1m in Q3 2012.
  • The order book was at 138.3m at the end of the quarter [Q3 2012: 151.4m] and has increased by 4.9% since the end of last quarter [131.8m].

Revenues for the first nine months of 2013 amounted to 493.4m and show a 7.9% decrease compared to the same period last year. This reflects challenging market situations and slower recovery than originally expected.  Operating profit (EBIT) YTD is 7.2% of revenues which is below the company´s target (10-12%) for the full year. Marel expects the EBIT margin in Q4 to be in line with Q3. 

Market conditions are still challenging with signals of improvements. While economic recovery seems to be gaining momentum in North-America, the Eurozone is still fragile and signals from emerging markets remain mixed with positive future prospects. Revenues from service and spare parts increased in Q3, while larger projects continue to be an uphill climb. Improved profit margins this quarter signal progress in operational efficiency and cost control despite delays of large projects.

Full year revenues 2013 are expected to decline by 6-8% compared with previous year. Marel  expects moderate growth of revenues next year on the heels of market recovery.

Theo Hoen, CEO:

“Marel is performing on a reasonable level considering market conditions.  The turnaround has been slower and more gradual than what we have seen before and had previously expected.  Lack of investments in large projects is affecting our revenue base. We remain confident that once the market bounces back we will capture increased demand with investment need building up. We saw this happen in 2009 when food processors delayed modernization of their equipment because of the economic uncertainty. Then in 2010 we saw it bounce back as the underlying demand for protein continued to grow as is the case now. In the meantime we are utilizing our extensive sales and service network to generate business by increased and better service to our customers. We remain optimistic about the future prospects and that´s why we will continue to maintain our network and a good level of investment in R&D while keeping our focus on operational efficiency”.  

5% increase in order book

Orders received amounted to 163.3m in the third quarter compared to 159.1m in Q2 2013. The order book amounted to 138.3m at the end of the third quarter compared with 131.8m at the end of Q2 [Q3 2012: 151.4m]. This represents an increase in the order book of around 5% compared with last quarter. This development reflects gradual recovery in Marel’s major markets while capturing that growth in the order book is still somewhat restrained by the absence of large projects.  This reflects the prolonged hesitation to invest in difficult market environment. Investment decisions now take longer than before. This applies to the market in general and Marel believes it is not losing market share. The company´s position in the market is strong and long term outlook for orders received is positive as the protein industry is expected to grow steadily in the coming years and need for investments is building up. 

Outlook                                                

Marel´s long term expected annual growth rate (CAGR) is 5-6%. The assumption that markets will recover has not changed but it is taking longer than anticipated. Marel expects that full year revenues will decline by 6-8% between years and anticipates moderate growth of revenues next year on the heels of market recovery.

Mid- and long-term, the company believes that Marel’s innovative products and global presence in all four industries will stimulate strong growth and increased profitability as the underlying market growth is still present.

It should be kept in mind that results may vary from quarter to quarter due to general economic developments, fluctuations in orders received and deliveries of larger systems.

See complete announcement in enclosed pdf. file.

 

Presentation of results, 24 October 2013

Marel will present its results at an investor meeting on Thursday, 24 October, at 8:30 am (GMT), at the company’s headquarters at Austurhraun 9, Gardabaer. The meeting will also be webcast at www.marel.com/webcast .

Publication days of Consolidated Financial Statements in 2014

4th quarter 2013                               5 February 2014

Annual General Meeting                  5 March 2014

1 st quarter 2014                                28 April 2014

2 nd quarter 2014                                23 July 2014

3 rd quarter 2014                                22 October 2014

4 th quarter 2014                                4 February 2015

Release of financial statements will take place after market closing at above-mentioned dates. 

For further information, contact:

Linda Jónsdóttir Corporate Director of Treasury and IR, tel: (+354) 563 8464 / mobile: (+354) 825 8464.

Auðbjörg Ólafsdóttir, Investor Relations specialist, tel: (+354) 563 8626 / mobile: (+354) 853 8626.

Erik Kaman, CFO, tel: (+354) 563 8072.

About Marel

Marel is the leading global provider of advanced equipment, systems and services to the fish, meat and poultry industries. With offices and subsidiaries in more than 30 countries and a global network of more than 100 agents and distributors, we work side-by-side with our customers to extend the boundaries of food processing performance. Advance with Marel for all your processing needs.

 

Forward-looking statements

Statements in this press release that are not based on historical facts are forward-looking statements.   Although such statements are based on management’s current estimates and expectations, forward-looking statements are inherently uncertain.  We, therefore, caution the reader that there are a variety of factors that could cause business conditions and results to differ materially from what is contained in our forward-looking statements, and that we do not undertake to update any forward-looking statements. All forward-looking statements are qualified in their entirety by this cautionary statement.

 

 

 

 

 



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us